Monoclonal antibody-drug conjugateFDA-approvedSecond-line
Ado-trastuzumab emtansine
How it works
Delivers a toxic payload to HER2-positive cancer cells, killing them.
Cancer types
Breast Cancer— HER2-positive
Efficacy
In clinical trials, ado-trastuzumab emtansine improved progression-free survival and response rates in HER2-positive patients with advanced breast cancer.
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.